Embryo cryopreservation feasible for women with breast cancer

Embryo cryopreservation feasible for women with breast cancer

(HealthDay)—For women with breast cancer, embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility, according to a study published online June 22 in the Journal of Clinical Oncology.

Kutluk Oktay, M.D., from New York Medical College in Valhalla, and colleagues provided pregnancy and outcomes for 131 women with . Participants underwent ovarian stimulation and received concurrent letrozole 5 mg per day before receiving and cryopreserving embryos.

The researchers found that 33 of the women (mean age, 41.5 ± 4.3 years) underwent 40 attempts to transfer embryos to their uterus (18 women) or via use of a gestation carrier (22 women) with a median of 5.25 years after embryo cryopreservation. Per embryo transfer, the overall live birth rate was similar to the U.S. national mean among similar-aged infertile women undergoing in vitro fertilization-embryo transfer (45.0 versus 38.2; P = 0.2). Overall, 38.8 percent of the 18 pregnancies were twins, with no higher-order pregnancies. After a mean follow-up of 40.4 ± 26.4 months, no fetal anomalies or malformations were reported. Seventeen of the 33 women had one or more children, with a fertility preservation rate of 51.5 percent.

"Embryo cryopreservation after with the letrozole and follicle-stimulating hormone protocol preserves fertility in women with breast cancer and results in pregnancy rates comparable to those expected in a noncancer population undergoing in vitro fertilization," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Journal of Clinical Oncology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Embryo cryopreservation feasible for women with breast cancer (2015, June 23) retrieved 23 September 2023 from https://medicalxpress.com/news/2015-06-embryo-cryopreservation-feasible-women-breast.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

No benefit in IVF from routinely freezing all embryos before transfer


Feedback to editors